Comerica Bank’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706 | Sell |
288
-815,701
| -100% | -$2M | ﹤0.01% | 3599 |
|
|
2025
Q1 | $5.44M | Buy |
815,989
+35,609
| +5% | +$238K | 0.02% | 622 |
|
|
2024
Q4 | $9.81M | Sell |
780,380
-5,146
| -0.7% | -$64.7K | 0.04% | 418 |
|
|
2024
Q3 | $14.5M | Buy |
785,526
+98,872
| +14% | +$1.83M | 0.06% | 326 |
|
|
2024
Q2 | $14.8M | Buy |
686,654
+152,129
| +28% | +$3.28M | 0.06% | 299 |
|
|
2024
Q1 | $14.4M | Sell |
534,525
-23,500
| -4% | -$633K | 0.06% | 313 |
|
|
2023
Q4 | $16.7M | Buy |
558,025
+117,949
| +27% | +$3.53M | 0.08% | 248 |
|
|
2023
Q3 | $9.02M | Buy |
+440,076
| New | +$9.02M | 0.05% | 393 |
|
|
2022
Q4 | $6.36M | Buy |
288,316
+39,806
| +16% | +$878K | 0.05% | 455 |
|
|
2022
Q3 | $4.07M | Buy |
248,510
+50
| +0% | +$818 | 0.03% | 629 |
|
|
2022
Q2 | $4.15M | Buy |
248,460
+116,503
| +88% | +$1.95M | 0.03% | 628 |
|
|
2022
Q1 | $1.81M | Buy |
131,957
+2,940
| +2% | +$40.2K | 0.01% | 1218 |
|
|
2021
Q4 | $2.12M | Buy |
129,017
+12,787
| +11% | +$210K | 0.02% | 1125 |
|
|
2021
Q3 | $3.42M | Sell |
116,230
-3,962
| -3% | -$116K | 0.02% | 926 |
|
|
2021
Q2 | $3.3M | Buy |
120,192
+39,487
| +49% | +$1.08M | 0.02% | 984 |
|
|
2021
Q1 | $3.62M | Buy |
80,705
+24,894
| +45% | +$1.12M | 0.02% | 950 |
|
|
2020
Q4 | $3.07M | Buy |
55,811
+26,665
| +91% | +$1.47M | 0.02% | 1026 |
|
|
2020
Q3 | $819K | Buy |
29,146
+3,280
| +13% | +$92.2K | 0.01% | 1677 |
|
|
2020
Q2 | $655K | Sell |
25,866
-5,285
| -17% | -$134K | 0.01% | 1745 |
|
|
2020
Q1 | $541K | Buy |
31,151
+4,086
| +15% | +$71K | 0.01% | 1695 |
|
|
2019
Q4 | $596K | Sell |
27,065
-1,090
| -4% | -$24K | ﹤0.01% | 1821 |
|
|
2019
Q3 | $363K | Buy |
28,155
+7,329
| +35% | +$94.5K | ﹤0.01% | 1997 |
|
|
2019
Q2 | $263K | Buy |
+20,826
| New | +$263K | ﹤0.01% | 2118 |
|